Martins, Tomás A. https://orcid.org/0000-0001-6016-2288
Kaymak, Deniz https://orcid.org/0000-0002-0233-3453
Tatari, Nazanin https://orcid.org/0000-0002-0003-6121
Gerster, Fiona https://orcid.org/0009-0000-6975-6517
Hogan, Sabrina https://orcid.org/0000-0003-3994-8109
Ritz, Marie-Françoise https://orcid.org/0000-0002-5650-9987
Sabatino, Valerio
Wieboldt, Ronja
Bartoszek, Ewelina M. https://orcid.org/0000-0001-5153-9258
McDaid, Marta
Gerber, Alexandra
Buck, Alicia https://orcid.org/0000-0001-9922-4474
Beshirova, Aisha https://orcid.org/0000-0001-9434-3423
Heider, Anja https://orcid.org/0000-0002-3448-4125
Shekarian, Tala
Mohamed, Hayget
Etter, Manina M.
Schmassmann, Philip
Abel, Ines
Boulay, Jean-Louis https://orcid.org/0000-0002-1401-7159
Saito, Yasuyuki https://orcid.org/0000-0002-9291-1383
Mariani, Luigi
Guzman, Raphael
Snijder, Berend https://orcid.org/0000-0003-3386-6583
Weiss, Tobias https://orcid.org/0000-0002-5533-9429
Läubli, Heinz https://orcid.org/0000-0002-8910-5620
Hutter, Gregor https://orcid.org/0000-0002-7570-3902
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (PP00P3_176974, 310030_215237/1, PP00P3_176974)
Krebsliga Schweiz (KFS-5763-02-2023, KFS-4382-02-2018, KFS-5789-02-2023)
Brain Tumour Charity (GN-000562)
Article History
Received: 25 October 2023
Accepted: 2 November 2024
First Online: 9 November 2024
Competing interests
: The authors declare the following competing interests: G.H. has equity in and is a co-founder of Incephalo Inc. H.L. is a member of the Scientific Advisory Board of GlycoEra and InterVenn and has received research support from Palleon Pharmaceuticals and consulting fees from Alector. Patent disclosure for the work described in this study: Chimeric antigen receptor constructs and uses thereof. International Patent Application No. PCT/EP2024/074131 on 30 August 2024. Assignee: the trustees of the University of Basel. Inventors: G.H., T.A.M. The remaining authors declare no competing interests.